Company Information: Shionogi & Co. Ltd.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4507","DATE":"2025-12-19","longName":"Shionogi & Co., Ltd.","company_name_ja":"\u5869\u91ce\u7fa9\u88fd\u85ac(\u682a)","fullTimeEmployees":6223,"address":"","phone":"","website":"https:\/\/www.shionogi.com","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":2716,"financialCurrency":"","marketCap":2311253,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":241.03999999999999,"epsForward":0,"bookValue":0,"totalRevenue":499677000000,"OperatingIncome":166725000000,"operatingMargins":33.369999999999997,"NetIncome":205159000000,"profitMargins":41.060000000000002,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":12.17,"recommendationMean":2.3333300000000001,"recommendationKey":"buy","targetMeanPrice":3387.5,"numberOfAnalystOpinions":11,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-07-01T06:14:11.394610\", \"ticker\": \"4507\", \"ticker_full\": \"4507.T\", \"company_name\": \"SHIONOGI & CO\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 0, \"buy\": 3, \"hold\": 8, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 11, \"recommendation_key\": \"buy\", \"recommendation_mean\": 2.33333}, \"target_prices\": {\"has_data\": true, \"current\": 2719.0, \"high\": 4000.0, \"low\": 2900.0, \"mean\": 3387.5, \"median\": 3300.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-07-30\", \"eps_estimate\": 42.54, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-01-29\", \"eps_estimate\": 68.45, \"eps_actual\": 87.76, \"surprise_pct\": 28.22}, {\"date\": \"2025-10-27\", \"eps_estimate\": 50.55, \"eps_actual\": 51.93, \"surprise_pct\": 2.73}, {\"date\": \"2025-07-28\", \"eps_estimate\": 42.54, \"eps_actual\": 46.26, \"surprise_pct\": 8.74}, {\"date\": \"2025-05-12\", \"eps_estimate\": 43.2, \"eps_actual\": 43.06, \"surprise_pct\": -0.33}, {\"date\": \"2025-01-31\", \"eps_estimate\": 44.31, \"eps_actual\": 59.56, \"surprise_pct\": 34.42}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 4.83, \"institution_pct\": 60.67, \"major_holders\": [{\"label\": \"\", \"value\": 4.83}, {\"label\": \"\", \"value\": 60.67}, {\"label\": \"\", \"value\": 63.76}, {\"label\": \"\", \"value\": 364.0}], \"institutional_holders\": [{\"holder\": \"Pacer Advisors, Inc.\", \"shares\": 465056, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.05, \"pct_change\": 6.79, \"value\": 1265184848}], \"mutualfund_holders\": [{\"holder\": \"VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund\", \"shares\": 20439649, \"date_reported\": \"2026-04-30\", \"pct_held\": 2.3, \"pct_change\": 9.65, \"value\": 55606065104}, {\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 11038464, \"date_reported\": \"2026-01-31\", \"pct_held\": 1.24, \"pct_change\": 0.84, \"value\": 30030141312}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 7273391, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.82, \"pct_change\": 2.14, \"value\": 19787260215}, {\"holder\": \"HARDING LOEVNER Fd.S INC-Harding Loevner Intl Eqy. PORT.\", \"shares\": 6241900, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.7, \"pct_change\": -3.79, \"value\": 16981088950}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 5390200, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.61, \"pct_change\": 0.59, \"value\": 14664039100}, {\"holder\": \"John Hancock Funds III-International Growth Fund\", \"shares\": 3206741, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.36, \"pct_change\": 0.0, \"value\": 8723938890}, {\"holder\": \"iShares, Inc.-iShares MSCI Japan ETF\", \"shares\": 3094800, \"date_reported\": \"2026-05-31\", \"pct_held\": 0.35, \"pct_change\": -1.01, \"value\": 8419403400}, {\"holder\": \"Fidelity Concord Street Trust-Fidelity International Index Fund\", \"shares\": 2816539, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.32, \"pct_change\": 1.22, \"value\": 7662394349}, {\"holder\": \"J.P. Morgan Exchange-Traded Fund Trust-JPMorgan BetaBuilders Japan ETF\", \"shares\": 2719200, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.31, \"pct_change\": 8.94, \"value\": 7397583600}, {\"holder\": \"iShares Trust-iShares MSCI EAFE ETF\", \"shares\": 2645600, \"date_reported\": \"2026-05-31\", \"pct_held\": 0.3, \"pct_change\": 0.96, \"value\": 7197354800}]}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":38,"get_dividend_history_year2":66,"get_dividend_history_year3":56.670000000000002,"get_dividend_history_year4":50,"get_dividend_history_year5":40,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-09T03:23:36.125606\", \"ticker\": \"4507\", \"ticker_full\": \"4507.T\", \"company_name\": \"SHIONOGI & CO\", \"company_info\": {\"name_en\": \"SHIONOGI & CO\", \"long_name\": \"Shionogi & Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.shionogi.com\", \"employees\": 6223, \"country\": \"Japan\", \"city\": \"Kita\", \"address\": \"Park Tower\", \"description\": \"Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 2813.4, \"deviation\": -0.12, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 2873.24, \"deviation\": -2.2, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 2922.45, \"deviation\": -3.85, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 2975.74, \"deviation\": -5.57, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 499677000000.0, \"revenue_fmt\": \"\u00a54997\u5104\", \"gross_profit\": 417226000000.0, \"gross_profit_fmt\": \"\u00a54172\u5104\", \"operating_income\": 166725000000.0, \"operating_income_fmt\": \"\u00a51667\u5104\", \"ebit\": 247521000000.0, \"ebit_fmt\": \"\u00a52475\u5104\", \"net_income\": 205159000000.0, \"net_income_fmt\": \"\u00a52052\u5104\", \"eps\": 241.04, \"operating_margin\": 33.37, \"total_assets\": 2576870000000.0, \"total_assets_fmt\": \"\u00a52.6T\", \"total_equity\": 1685215000000.0, \"total_equity_fmt\": \"\u00a51.7T\", \"total_debt\": 684394000000.0, \"total_debt_fmt\": \"\u00a56844\u5104\", \"total_cash\": 711397000000.0, \"total_cash_fmt\": \"\u00a57114\u5104\", \"equity_ratio\": 65.4, \"de_ratio\": 0.41, \"current_ratio\": 1.58, \"operating_cf\": 213572000000.0, \"operating_cf_fmt\": \"\u00a52136\u5104\", \"investing_cf\": -506137000000.0, \"investing_cf_fmt\": \"-\u00a55061\u5104\", \"financing_cf\": 599321000000.0, \"financing_cf_fmt\": \"\u00a55993\u5104\", \"free_cf\": 182268000000.0, \"free_cf_fmt\": \"\u00a51823\u5104\", \"net_margin\": 41.06, \"roe\": 12.17, \"roa\": 7.96}, {\"year\": 2025, \"revenue\": 438268000000.0, \"revenue_fmt\": \"\u00a54383\u5104\", \"gross_profit\": 374441000000.0, \"gross_profit_fmt\": \"\u00a53744\u5104\", \"operating_income\": 156604000000.0, \"operating_income_fmt\": \"\u00a51566\u5104\", \"ebit\": 209777000000.0, \"ebit_fmt\": \"\u00a52098\u5104\", \"net_income\": 170435000000.0, \"net_income_fmt\": \"\u00a51704\u5104\", \"eps\": 0, \"operating_margin\": 35.73, \"total_assets\": 1535349000000.0, \"total_assets_fmt\": \"\u00a51.5T\", \"total_equity\": 1361924000000.0, \"total_equity_fmt\": \"\u00a51.4T\", \"total_debt\": 21882000000.0, \"total_debt_fmt\": \"\u00a5219\u5104\", \"total_cash\": 374795000000.0, \"total_cash_fmt\": \"\u00a53748\u5104\", \"equity_ratio\": 88.7, \"de_ratio\": 0.02, \"current_ratio\": 6.63, \"operating_cf\": 195460000000.0, \"operating_cf_fmt\": \"\u00a51955\u5104\", \"investing_cf\": -116080000000.0, \"investing_cf_fmt\": \"-\u00a51161\u5104\", \"financing_cf\": -64908000000.0, \"financing_cf_fmt\": \"-\u00a5649\u5104\", \"free_cf\": 143357000000.0, \"free_cf_fmt\": \"\u00a51434\u5104\", \"net_margin\": 38.89, \"roe\": 12.51, \"roa\": 11.1}, {\"year\": 2024, \"revenue\": 435081000000.0, \"revenue_fmt\": \"\u00a54351\u5104\", \"gross_profit\": 377479000000.0, \"gross_profit_fmt\": \"\u00a53775\u5104\", \"operating_income\": 153312000000.0, \"operating_income_fmt\": \"\u00a51533\u5104\", \"ebit\": 204984000000.0, \"ebit_fmt\": \"\u00a52050\u5104\", \"net_income\": 162030000000.0, \"net_income_fmt\": \"\u00a51620\u5104\", \"eps\": 186.11, \"operating_margin\": 35.24, \"total_assets\": 1416918000000.0, \"total_assets_fmt\": \"\u00a51.4T\", \"total_equity\": 1235325000000.0, \"total_equity_fmt\": \"\u00a51.2T\", \"total_debt\": 11620000000.0, \"total_debt_fmt\": \"\u00a5116\u5104\", \"total_cash\": 358090000000.0, \"total_cash_fmt\": \"\u00a53581\u5104\", \"equity_ratio\": 87.18, \"de_ratio\": 0.01, \"current_ratio\": 5.86, \"operating_cf\": 154284000000.0, \"operating_cf_fmt\": \"\u00a51543\u5104\", \"investing_cf\": 5922000000.0, \"investing_cf_fmt\": \"\u00a559\u5104\", \"financing_cf\": -126853000000.0, \"financing_cf_fmt\": \"-\u00a51269\u5104\", \"free_cf\": 126017000000.0, \"free_cf_fmt\": \"\u00a51260\u5104\", \"net_margin\": 37.24, \"roe\": 13.12, \"roa\": 11.44}, {\"year\": 2023, \"revenue\": 426684000000.0, \"revenue_fmt\": \"\u00a54267\u5104\", \"gross_profit\": 364437000000.0, \"gross_profit_fmt\": \"\u00a53644\u5104\", \"operating_income\": 149004000000.0, \"operating_income_fmt\": \"\u00a51490\u5104\", \"ebit\": 224832000000.0, \"ebit_fmt\": \"\u00a52248\u5104\", \"net_income\": 184965000000.0, \"net_income_fmt\": \"\u00a51850\u5104\", \"eps\": 207.03, \"operating_margin\": 34.92, \"total_assets\": 1311800000000.0, \"total_assets_fmt\": \"\u00a51.3T\", \"total_equity\": 1100046000000.0, \"total_equity_fmt\": \"\u00a51.1T\", \"total_debt\": 9411000000.0, \"total_debt_fmt\": \"\u00a594\u5104\", \"total_cash\": 309224000000.0, \"total_cash_fmt\": \"\u00a53092\u5104\", \"equity_ratio\": 83.86, \"de_ratio\": 0.01, \"current_ratio\": 4.95, \"operating_cf\": 177867000000.0, \"operating_cf_fmt\": \"\u00a51779\u5104\", \"investing_cf\": -48292000000.0, \"investing_cf_fmt\": \"-\u00a5483\u5104\", \"financing_cf\": -84123000000.0, \"financing_cf_fmt\": \"-\u00a5841\u5104\", \"free_cf\": 140680000000.0, \"free_cf_fmt\": \"\u00a51407\u5104\", \"net_margin\": 43.35, \"roe\": 16.81, \"roa\": 14.1}, {\"year\": 2022, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 126.21, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 40.0}, {\"year\": 2023, \"amount\": 50.0}, {\"year\": 2024, \"amount\": 56.67}, {\"year\": 2025, \"amount\": 66.0}, {\"year\": 2026, \"amount\": 38.0}], \"latest\": 38.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-6919","company","type-company","status-publish","hentry"],"yoast_head":"\n